Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug un

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down double digits in premarket trading. CagriSema, ... Read more

Bron:

Fast Company